Tech Company Financing Transactions

Selexys Pharmaceuticals Funding Round

Selexys Pharmaceuticals closed a $23 million Series A venture capital round on 9/19/2012. Investors included MPM Capital and private investors.

Transaction Overview

Announced On
9/19/2012
Transaction Type
Venture Equity
Amount
$23,000,000
Round
Series A
Investors

MPM Capital (Lead Investor) (Todd Foley)

Proceeds Purpose
The combination of the Novartis agreement and the closing of the Series A financing will allow Selexys to advance the SelG1 program through a large Phase 2 clinical study in sickle cell patients and will also fund a second program at Selexys, an anti-PSGL-1 antibody, through a Phase I clinical study.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
840 Research Parkway 510
Oklahoma City, OK 73104
USA
Email Address
Overview
Selexys Pharmaceuticals Corporation (Selexys) is a privately held company that is developing drugs to treat inflammatory and thrombotic diseases.
Profile
Selexys Pharmaceuticals LinkedIn Company Profile
Social Media
Selexys Pharmaceuticals Company Twitter Account
Company News
Selexys Pharmaceuticals News
Facebook
Selexys Pharmaceuticals on Facebook
YouTube
Selexys Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Scott Rollins
  Scott Rollins LinkedIn Profile  Scott Rollins Twitter Account  Scott Rollins News  Scott Rollins on Facebook
Chief Medical Officer
Rodger McEver
  Rodger McEver LinkedIn Profile  Rodger McEver Twitter Account  Rodger McEver News  Rodger McEver on Facebook
Chief Scientific Officer
Richard Cummings
  Richard Cummings LinkedIn Profile  Richard Cummings Twitter Account  Richard Cummings News  Richard Cummings on Facebook
VP - Bus. Development
David Falconer
  David Falconer LinkedIn Profile  David Falconer Twitter Account  David Falconer News  David Falconer on Facebook
VP - Operations
Richard Alvarez
  Richard Alvarez LinkedIn Profile  Richard Alvarez Twitter Account  Richard Alvarez News  Richard Alvarez on Facebook


 

 

Browse more venture capital transactions:

Prev: 9/19/2012: Familiar venture capital transaction
Next: 9/19/2012: Xcovery Vision venture capital transaction

 

Share this article

 


About Our VC Transactions Data

We report on all VC transactions involving tech companies. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary